Renewal season

Food, drug, and medical device renewals open October 1. Renewal season opens Oct 1 Switch your US Agent for $299/year. No hidden fees.

Switch todaySwitch

ECTD Publishing Services

eCTD Publishing Services for FDA Regulatory Submissions

eCTD, the Electronic Common Technical Document, is the mandatory format for all regulatory submissions to the FDA, including IND, NDA, ANDA, and DMF filings. FDABasics handles eCTD compilation, formatting, validation, and submission through the FDA Electronic Submissions Gateway on behalf of foreign and domestic drug companies. We have served clients in 100+ countries since 1995 and hold 5-star ratings on Trustpilot and Google.

A technical rejection from the FDA for a formatting or validation error can delay your application review by weeks. FDABasics prepares and validates your eCTD before submission so your application is accepted the first time.

eCTD Publishing Services for FDA Regulatory Submissions

eCTD, the Electronic Common Technical Document, is the mandatory format for all regulatory submissions to the FDA, including IND, NDA, ANDA, and DMF filings. FDABasics handles eCTD compilation, formatting, validation, and submission through the FDA Electronic Submissions Gateway on behalf of foreign and domestic drug companies. We have served clients in 100+ countries since 1995 and hold 5-star ratings on Trustpilot and Google.

A technical rejection from the FDA for a formatting or validation error can delay your application review by weeks. FDABasics prepares and validates your eCTD before submission so your application is accepted the first time.

What Is eCTD and Why Is It Required?

The Electronic Common Technical Document (eCTD) is the standardized electronic format the FDA requires for all regulatory submissions. It organizes your submission into five modules, each covering a specific area of your application, from administrative documents through quality data, nonclinical studies, and clinical trial reports.

The FDA has required eCTD format for most drug submissions since 2017. Submissions that do not meet the eCTD technical specifications are rejected by the FDA's Electronic Submissions Gateway before they ever reach a reviewer. The rejection does not pause your review clock, it simply means your submission was never received.

eCTD submission Electronic Common Technical Document — required for all IND, NDA, ANDA, and DMF filings Module 1 Administrative information Cover letters, forms, labels Region-specific (US = FDA 356h) Module 2 Common technical document Quality, nonclinical, and clinical summaries and overviews Module 3 Quality Drug substance and drug product Module 4 Nonclinical Pharmacology, toxicology, PK Module 5 Clinical Study reports, literature references Submitted via FDA Electronic Submissions Gateway (ESG) IND NDA ANDA DMF FDABasics eCTD publishing services We compile, validate, and submit your eCTD through the FDA Electronic Submissions Gateway. Our team handles SPL formatting, sequence numbering, validation checks, and re-submission if FDA issues a technical rejection. Available for IND, NDA, ANDA, and DMF filings.

What FDABasics Handles

eCTD publishing is more than converting documents into a folder structure. A compliant eCTD submission requires specific formatting, correct sequencing, valid XML backbone files, and conformance with the FDA's eCTD technical specifications. Our team manages every step.

eCTD compilation and formatting We organize your documents into the correct module and section structure, apply the required naming conventions, and build the XML backbone that tells the FDA's systems how to read and navigate your submission.

Validation Before submission, we run your eCTD through validation software to check for technical errors. Common issues include invalid file formats, broken hyperlinks, incorrect metadata, and sequence numbering errors. We resolve all validation failures before the file leaves our team.

Submission through the FDA Electronic Submissions Gateway (ESG) We transmit your completed eCTD directly to the FDA through the official ESG system and provide you with the acknowledgment and confirmation documents once the submission is received.

Re-submission support If the FDA issues a technical rejection or requests a corrected submission, we handle the correction and re-transmission at no additional charge.

Submission Types We Support

FDABasics provides eCTD publishing services for all major FDA drug submission types.

IND (Investigational New Drug) Required before beginning clinical trials in the United States. The IND submission includes the protocol, investigator information, and available preclinical data in eCTD format.

NDA (New Drug Application) Required for approval of a new brand-name drug for US marketing. NDAs are among the most complex regulatory submissions and require complete eCTD formatting across all five modules.

ANDA (Abbreviated New Drug Application) Required for approval of a generic drug. ANDAs must demonstrate bioequivalence to the reference listed drug and are submitted in eCTD format.

DMF (Drug Master File) A confidential submission providing the FDA with detailed information about your facility, processes, or components referenced in another company's application. Type II API DMFs are most commonly required by generic drug manufacturers. FDABasics provides DMF filing in eCTD format.

Why Drug Companies Choose FDABasics for eCTD

A single formatting error in an eCTD submission can result in a technical rejection that delays your application review by weeks. Choosing an experienced eCTD publisher means your submission is prepared correctly before it reaches the FDA.

  • 30+ Years of FDA Regulatory Experience
  • eCTD submissions validated before every filing
  • Direct ESG submission with acknowledgment confirmation provided
  • Re-submission support included at no extra charge
  • Competitive fees with plans available for small businesses
  • 5-Star Rated on Trustpilot and Google
  • US-Based Team Serving Drug Companies in 100+ Countries
  • Strict Client Confidentiality

Get Started with these Top Drug Establishment Forms

  • =
    US Agent for Foreign Establishment
  • =
    Drug Establishment Registration Form
  • =
    NDC Labeler Code Form
  • =
    Drug Listing Form
  • =
    GDUFA Self Identification Form
  • =
    Drug Establishment FEI Number Form